MABWELL (SHANGHAI) BIOSCIENCE CO LT revenue breakdown overview

MABWELL (SHANGHAI) BIOSCIENCE CO LT revenue for the last year amounted to 200.00 M CNY, the most of which — 144.59 M CNY — came from its highest performing source at the moment, Antibody Drugs, the year earlier bringing 42.09 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought MABWELL (SHANGHAI) BIOSCIENCE CO LT 148.58 M CNY, and the year before that — 59.12 M CNY.